Skip to main content

Table 2 The relationship between OBS and uricemia

From: Nonlinear relationship between oxidative balance score and hyperuricemia: analyses of NHANES 2007–2018

 

Model1

Model2

Model3

Characteristic

OR1

95% CI1

P-value

OR1

95% CI1

P-value

OR1

95% CI1

P-value

Total OBS continuous

0.97

(0.96, 0.98)

< 0.001

0.96

(0.95, 0.97)

< 0.001

0.97

(0.96, 0.98)

< 0.001

Total OBS quantile

Q1

ref.

ref.

 

ref.

ref.

 

ref.

ref.

 

Q2

0.86

(0.75, 0.98)

0.03

0.82

(0.70, 0.96)

0.012

0.86

(0.74, 1.01)

0.069

Q3

0.81

(0.69, 0.94)

0.006

0.75

(0.63, 0.90)

0.003

0.8

(0.67, 0.97)

0.023

Q4

0.56

(0.46, 0.68)

< 0.001

0.49

(0.39, 0.62)

< 0.001

0.55

(0.44, 0.70)

< 0.001

p for trend

0.67

(0.59, 0.76)

< 0.001

0.61

(0.52, 0.71)

< 0.001

0.66

(0.56, 0.78)

< 0.001

  1. OR, odds ratio; CI, confidence intervals; OBS, oxidative balance score
  2. Q1: 0 ≤ Total OBS<14; Q2: 14 ≤ Total OBS<20; Q3: 20 ≤ Total OBS<26; Q4: Total OBS ≥ 26.
  3. The model 1 was the crude model
  4. The model 2 was adjusted by age, gender, race, poverty-to-income ratio, energy intake, caffeine intake, protein intake and sugar intake
  5. The model 3 was adjusted by age, gender, race/ethnicity, poverty-to-income ratio, CKD, diabetes, hypertension, hyperlipidemia, CVD, energy intake, caffeine intake, protein intake and sugar intake